effect
vaccin
base
three
critic
aspect
bcell
respons
toward
infecti
agent
bcell
gener
specif
antibodi
toward
vast
molecular
divers
antigen
protein
sugar
dna
lipid
seem
limit
abil
rais
antibodi
everyth
ii
stimul
bcell
perfect
antibodi
affin
matur
complement
everi
nook
cranni
epitop
iii
pathogen
remain
genet
stabl
chang
great
extent
thu
antibodi
produc
vaccin
subsequ
boost
recogn
viral
virul
field
isol
futur
encount
effect
knock
howev
vaccin
target
flu
viru
hiv
extrem
genet
dynam
rapid
genet
drift
virus
render
move
target
assist
abil
evad
immun
surveil
postul
case
hypervari
pathogen
bcell
respons
actual
might
good
propos
restrict
bcell
activ
may
prove
effect
counteract
genet
divers
variant
virus
flu
hiv
suggest
two
level
bcell
restrict
focu
bcell
respons
exclus
toward
neutral
epitop
creat
epitopebas
immunogen
ii
restrict
affin
matur
bcell
prevent
product
overli
optim
exquisit
specif
antibodi
togeth
bcell
restrict
provid
new
modal
vaccin
design
articl
histori
epitop
base
vaccin
fuzzi
vaccin
broad
cross
neutral
affin
matur
subunit
vaccin
flu
vaccin
aid
vaccin
humor
respons
bcell
immun
train
immun
system
vaccin
proven
enorm
effect
mean
prevent
diseas
save
live
sinc
jenner
million
million
children
worldwid
protect
yearli
diseas
mani
countri
societi
almost
forgotten
threat
past
gener
principl
vaccin
rather
simpl
straightforward
train
immun
system
dummi
pathogen
gain
experi
protect
event
encount
virul
form
futur
yet
vaccin
work
other
long
pathogen
remain
genet
stabl
vaccin
prove
amazingli
effect
measl
mump
rubella
vaccin
afford
lifelong
protect
chang
littl
sinc
first
licens
smallpox
vaccineerad
polio
much
success
vaccin
lie
abil
deposit
store
reservoir
train
bcell
abl
produc
finetun
highli
effici
neutral
antibodi
consequ
futur
encount
virul
field
virusisol
met
immedi
crossreact
secondari
respons
perfect
readi
knockout
intrus
three
properti
bcell
respons
contribut
much
toward
success
prophylaxi
abil
produc
highli
specif
discrimin
lead
antibodi
everyth
tonegawa
discov
abil
chromosom
rearrang
produc
vjvdj
junction
breakthrough
crack
longlast
perplex
conundrum
open
read
frame
genom
abl
produc
million
million
uniqu
antibodi
product
distinct
bcell
clone
wealth
antibodi
increas
introduct
p
n
nucleotid
combinatori
junction
thu
seem
limit
divers
antibodi
abl
produc
antigen
protein
nucleic
acid
sugar
well
lipid
long
even
margin
affin
bcell
receptor
bcr
epitop
immunogen
clonal
expans
launch
everimprov
antibodi
gener
abil
perfect
exquisit
specif
antibodi
somat
hypermut
accompani
multipl
round
immunogenbcel
encount
step
lead
affin
matur
initi
bind
event
pathogen
bcell
launch
clonal
expans
product
lead
igm
antibodi
initi
efficaci
rel
broadspectrum
weak
binder
counteract
invad
pathogen
lie
avid
gain
decaval
igm
howev
aidmedi
mutagenesi
variabl
domain
kick
fit
cdr
loop
idiosyncrasi
epitop
bound
gradual
improv
mutat
follow
select
bcell
clone
gain
everincreas
affin
drive
antibodi
perfect
abil
continu
clear
pathogen
concentr
ever
decreas
ultim
optim
contact
jonathan
gershoni
gershoni
tauextauacil
antibodi
produc
whose
paratop
neatli
complement
nook
cranni
epitop
precis
exhibit
bind
affin
kd
deposit
recal
matur
memori
cell
process
develop
perfect
bcell
respons
take
time
howev
natur
encount
virul
pathogen
time
critic
give
pathogen
opportun
replic
establish
lifethreaten
infect
vaccin
hand
afford
immun
system
chanc
studi
harmless
version
pathogen
elicit
clonal
expans
select
bcell
abil
go
repeat
round
somat
hypermut
perfect
affin
matur
antibodi
success
vaccin
lie
option
train
effect
bcell
store
matur
memori
cell
absenc
diseas
recal
upon
demand
archiv
perfect
memori
bcell
clone
ensur
futur
encount
virul
field
isol
pathogen
met
immedi
bcell
frenzi
secret
perfectli
match
antibodi
intercept
pathogen
knock
infect
set
diseas
ensu
despit
impress
collect
pathogen
vaccin
proven
remark
effect
virus
simpli
compli
attempt
produc
protect
vaccin
hiv
fail
influenza
continu
challeng
adversari
numer
differ
strategi
employ
virus
evad
immun
follow
exampl
tactic
virus
use
interfer
abil
bcell
mount
potent
longlast
crossreact
neutral
antibodi
conceal
neutral
epitop
antibodymedi
neutral
base
bcell
target
critic
neutral
epitop
viru
virus
exampl
gain
entri
target
hostcel
exploit
cell
surfaceprotein
serv
receptor
obvious
receptor
bind
site
rb
viral
spike
protein
thu
present
good
neutral
epitop
antibodi
bind
thu
occlud
rb
prevent
viru
abl
associ
target
cell
surfac
henc
keep
rb
conceal
reduc
immunogen
bind
site
tend
buri
crypt
certainli
much
less
access
surround
surfac
spike
protein
therefor
gener
prime
neutral
epitop
less
avail
bcell
scrutini
shadow
neutral
surfac
glycanshield
anoth
strategi
employ
virus
viral
spike
protein
typic
highli
glycosyl
glycomoieti
loom
surfac
viru
shadow
access
underli
spike
aminoacid
surfac
thu
access
immunogen
aspect
spike
limit
steric
hindranc
impos
multipl
glycan
branch
stem
strateg
posit
n
glycosyl
site
spike
display
multipl
nonneutr
epitop
viral
surfac
contain
select
truli
critic
neutral
epitop
may
hidden
shadow
said
extens
access
surfac
spike
interact
bcell
enorm
divers
bcell
complement
liter
everi
antigen
surfac
viru
thu
lead
plethora
gener
useless
antibodi
inde
hiv
influenza
stimul
robust
serolog
respons
upon
infect
howev
vast
major
antibodi
produc
littl
counteract
invas
flood
system
impot
antibodi
reduc
viral
load
degre
realli
perturb
infecti
process
special
case
distract
target
realiz
shed
chaff
solubl
spike
compon
dispens
chaff
fals
target
viral
spike
often
contain
multipl
subunit
exampl
cleav
produc
membraneanchor
noncoval
associ
solubl
matur
spike
assembl
form
trimer
consist
three
monom
buri
innersurfac
monom
meet
produc
trimer
contain
neutral
epitop
surfac
never
expos
nativ
function
spike
howev
shed
monomer
serum
reveal
previous
buri
surfac
spike
bcell
target
decoy
fals
target
viru
dissuad
immun
evad
chafflik
shed
dynam
genet
variat
success
polio
smallpox
vaccin
lie
virus
tend
genet
stabl
howev
hiv
influenza
exhibit
extens
genet
instabl
virus
evolv
uniqu
mechan
increas
genet
variat
rnadnarna
cycl
hiv
genom
via
revers
transcriptas
highli
errorpron
influenza
benefit
genet
drift
shift
dynam
instabl
produc
vast
amount
variant
virus
mani
may
nonproduct
progeni
howev
replic
cycl
viru
amino
acid
composit
variationsmut
produc
compromis
viral
infect
mutant
viru
variant
may
recogn
antibodi
previous
rais
origin
viral
infecti
isol
thu
offer
escap
rout
viru
abil
evad
immun
case
bcell
respons
might
good
dynam
dialogu
pathogen
immun
defens
lead
serial
round
coevolut
bcell
encount
vast
repertoir
epitop
present
viru
viru
evolv
best
conceal
vulner
target
turn
present
multipl
distract
nonneutr
epitop
bank
fact
bcell
indiscrimin
bind
respond
everyth
multipl
antibodi
produc
hit
critic
neutral
epitop
howev
initi
round
somat
hypermut
go
optim
affin
precis
target
complement
founder
infecti
strain
viru
affinitymatur
proce
antibodi
focu
gain
perfect
specif
strain
initi
encount
lose
abil
bind
diverg
viral
genet
variant
yet
emerg
perfect
highli
targetspecif
neutral
affinitymatur
antibodi
goe
hand
hand
loss
broad
crossreact
allow
recognit
ever
variant
member
evolv
viral
swarm
perfect
potent
exquisit
specif
neutral
antibodi
open
back
door
viral
mutat
escap
scrutini
go
spread
infect
havoc
curious
two
strong
point
bcell
physiolog
abil
bind
react
everyth
ii
affinityperfect
antibodi
provid
advantag
challeng
viru
target
hypervari
constantli
chang
lure
bcell
fals
direct
paradox
might
prove
best
strategi
product
vaccin
toward
hypervari
virus
like
hiv
influenza
restrict
bcell
respons
view
seemingli
endless
capac
bcell
gener
antibodi
toward
everi
nuanc
infecti
viru
would
make
sens
restrict
focu
immun
respons
exclus
toward
neutral
epitop
certainli
make
sens
invest
bcell
energi
produc
except
effect
antibodi
antibodi
ensur
bind
event
crippl
viru
directli
interfer
infect
first
restrict
bcell
respons
toward
virus
prevent
product
antibodi
nonneutr
surfac
viru
tri
focu
immun
respons
everi
antibodi
count
number
approach
use
restrict
focu
bcell
respons
assum
one
map
prefer
neutral
surfac
given
viru
might
possibl
accentu
target
occlud
shield
otherwis
distract
surfac
strateg
place
glycomoieti
shield
surfac
spike
protein
propos
leav
neutral
surfac
expos
subject
bcell
scrutini
essenc
use
trimer
spike
protein
case
sosip
trimer
ensur
inner
surfac
chaff
decoy
avoid
one
mean
better
focu
respons
toward
select
neutral
epitop
would
remov
otherwis
distract
antigen
subunit
vaccin
first
step
toward
goal
instead
vaccin
intact
pertussi
bacterium
protein
acellular
vaccin
present
immun
system
hand
relev
pertussi
antigen
similarli
hepat
b
surfac
antigen
good
exampl
success
subunit
vaccin
recent
human
papilloma
viru
subunit
vaccin
illustr
use
recombin
capsid
protein
reduc
occurr
cervic
cancer
one
abl
dissect
neutral
epitop
exclus
could
lead
ultim
form
target
vaccin
ie
epitopebas
vaccin
natur
neutral
epitop
first
need
map
precis
systemat
remov
viral
surfac
leav
desir
epitop
immunogen
obvious
simpl
task
epitop
discontinu
highli
conform
expect
simpli
express
correct
peptid
sequenc
correspond
epitop
nativ
conform
function
epitop
surfac
would
achiev
address
task
epitop
reconstitut
implement
novel
combinatori
approach
rb
sar
coronaviru
sar
cov
contain
subdomain
viral
spike
actual
surfac
contact
viral
receptor
less
amino
acid
residu
situat
two
discontinu
antiparallel
beta
strand
use
combinatori
linker
bridg
two
strand
bona
fide
rb
enabl
affin
select
function
reconstitut
neutral
epitop
viru
approach
sinc
found
effect
reconstitut
neutral
epitop
mer
coronaviru
dengu
viru
publish
focus
immun
respons
exclus
neutral
epitop
may
particularli
import
dengu
prevent
may
obviat
develop
antibodydepend
enhanc
ade
henc
first
level
bcell
restrict
improv
vaccin
discard
irrelev
distract
pathogen
antigen
focu
bcell
respons
exclus
count
toward
neutral
epitop
curious
perfect
antibodi
via
affin
matur
might
overdo
case
evolut
humor
immun
system
may
abl
predict
hypervari
pathogen
well
shift
drift
virus
like
flu
thu
drive
antibodi
perfect
gain
extrem
specif
high
affin
ensur
abil
clear
pathogen
concentr
dwindl
initi
kd
first
gener
antibodi
paradox
precis
boon
dynam
chang
viru
oppon
natur
first
gener
respons
bit
fuzzi
recognit
toler
epitop
variat
need
recogn
handl
viru
may
infect
us
therefor
germlin
respons
tend
crossreact
loosefit
paratop
bind
enough
launch
clonal
expans
multipl
round
perfect
follow
produc
ultimatefit
antibodi
target
initi
infecti
viru
gain
specif
affin
howev
expens
loss
flexibl
toler
crossreact
thu
viru
accumul
mutat
genet
variant
gradual
morph
slowli
escap
rang
recognit
perfect
highaffin
antibodi
matur
one
could
restrict
bcell
respons
might
prove
answer
dynam
genet
drift
one
could
stimul
earli
bcell
lineag
yet
prevent
affin
matur
fuzzi
vaccin
would
possibl
fuzzyvaccin
would
train
system
forg
ahead
develop
antibodi
singl
variant
specif
rather
prefer
germlin
bcell
would
activ
allow
affin
matur
beyond
certain
point
thu
gain
abil
cope
infecti
isol
also
emerg
variant
yet
appear
henc
second
mode
bcell
restrict
teach
system
happi
crossreact
antibodi
mediocr
degre
precis
need
counteract
genet
drift
emerg
viru
variat
produc
fuzzi
vaccin
challeng
worth
meet
immun
system
evolv
effect
counteract
elimin
infecti
virus
vaccin
effect
medic
intervent
sinc
immun
first
discov
howev
virus
paradigm
train
immun
system
discret
immunogen
faith
repres
nativ
pathogen
entireti
simpli
work
evolut
viru
fast
movingtarget
hypervari
speci
evad
canon
expect
bcell
respons
present
challeng
vaccin
industri
nextgener
biotechnolog
ingenu
must
step
understand
natur
bcell
respons
extens
one
mean
outwit
counter
influenza
play
outsid
box
viru
evolut
anticip
paradox
one
way
achiev
goal
bcell
restrict
concept
describ
product
numer
discuss
student
mani
year
privileg
collabor
especi
thank
dr
anna
roitburdberman
dr
yael
weissottolenghi
chen
piller
critic
comment
assist
make
articl
possibl
potenti
conflict
interest
report
author
